Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 121 AL 135

Alzheimer's Disease Caregivers' Health and Important Resources: Next Steps in Intervention Research

Ross KM, Carroll JE.

Psychosom Med. 2017 Sep;79(7):732-734. doi: 10.1097/PSY.0000000000000518.

Supporting people with young onset dementia and their families: An evaluation of a training course for care workers

Smith R, Ooms A, Greenwood N.

Nurse Educ Pract. 2017 Nov;27:7-12. doi: 10.1016/j.nepr.2017.08.007. Epub 2017 Aug 8.

Study protocol: pragmatic randomized control trial of an internet-based intervention (My tools 4 care) for family carers

Duggleby W, Ploeg J, McAiney C, Fisher K, Swindle J, Chambers T, Ghosh S, Peacock S, Markle-Reid M, Triscott J, Williams A, Forbes D, Pollard L.

BMC Geriatr. 2017 Aug 14;17(1):181. doi: 10.1186/s12877-017-0581-6.

Supporting Adults With Alzheimer's Disease and Related Major Neurocognitive Disorders and Their Caregivers: Effective Occupational Therapy Interventions

Smallfield S.

Am J Occup Ther. 2017 Sep/Oct;71(5):7105170010p1-7105170010p4. doi: 10.5014/ajot.2017.715002.

Effectiveness of Interventions for Caregivers of People With Alzheimer's Disease and Related Major Neurocognitive Disorders: A Systematic Review

Piersol CV, Canton K, Connor SE, Giller I, Lipman S, Sager S.

Am J Occup Ther. 2017 Sep/Oct;71(5):7105180020p1-7105180020p10. doi: 10.5014/ajot.2017.027581.

APP/Aβ structural diversity and Alzheimer's disease pathogenesis

Roher AE, Kokjohn TA, Clarke SG, Sierks MR, Maarouf CL, Serrano GE, Sabbagh MS, Beach TG.

Neurochem Int. 2017 Nov;110:1-13. doi: 10.1016/j.neuint.2017.08.007. Epub 2017 Aug 12.

Clinical Use and Utility of Amyloid Imaging

Barthel H, Sabri O.

J Nucl Med. 2017 Nov;58(11):1711-1717. doi: 10.2967/jnumed.116.185017. Epub 2017 Aug 17.

Small-molecule PET Tracers for Imaging Proteinopathies

Mathis CA, Lopresti BJ, Ikonomovic MD, Klunk WE.

Semin Nucl Med. 2017 Sep;47(5):553-575. doi: 10.1053/j.semnuclmed.2017.06.003. Epub 2017 Jul 13.

Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years

Wattmo C, Wallin ÅK.

Alzheimers Res Ther. 2017 Aug 31;9(1):70. doi: 10.1186/s13195-017-0294-2.

Changes in brain amyloid-β accumulation after donepezil administration

Ishibashi K, Miura Y, Wagatsuma K, Ishiwata K, Ishii K.

J Clin Neurosci. 2017 Nov;45:328-329. doi: 10.1016/j.jocn.2017.08.025. Epub 2017 Aug 31.

Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study

Polak T, Herrmann MJ, Müller LD, Zeller JBM, Katzorke A, Fischer M, Spielmann F, Weinmann E, Hommers L, Lauer M, Fallgatter AJ, Deckert J.

J Neural Transm (Vienna). 2017 Nov;124(11):1473-1488. doi: 10.1007/s00702-017-1781-0. Epub 2017 Sep 1.

Advancing Alzheimer's research: A review of big data promises

Zhang R, Simon G, Yu F.

Int J Med Inform. 2017 Oct;106:48-56. doi: 10.1016/j.ijmedinf.2017.07.002. Epub 2017 Jul 24.

Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease

Ameen-Ali KE, Wharton SB, Simpson JE, Heath PR, Sharp P, Berwick J.

Neuropathol Appl Neurobiol. 2017 Dec;43(7):553-570. doi: 10.1111/nan.12440.

Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease

Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A.

Br J Pharmacol. 2017 Dec;174(23):4224-4232. doi: 10.1111/bph.14030. Epub 2017 Oct 29.

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease

Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, Houot M, Lehéricy S, Teipel S, Dubois B, Hampel H; Hippocampus Study Group.

Sci Rep. 2017 Sep 15;7(1):11706. doi: 10.1038/s41598-017-09780-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias